Urinary sodium and potassium excretion and risk of cardiovascular events. - Wikidata - wikimedia - TriplyDB

Urinary sodium and potassium excretion and risk of cardiovascular events.

Urinary sodium and potassium excretion and risk of cardiovascular events.

http://www.wikidata.org/entity/Q46714861

about

Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses Reduced dietary salt for the prevention of cardiovascular disease Effect of longer-term modest salt reduction on blood pressure Nutritional strategies for skeletal and cardiovascular health: hard bones, soft arteries, rather than vice versa Food Consumption and its Impact on Cardiovascular Disease: Importance of Solutions Focused on the Globalized Food System: A Report From the Workshop Convened by the World Heart Federation.Salt, blood pressure and cardiovascular risk: what is the most adequate preventive strategy? A Swiss perspective Whole grains, type 2 diabetes, coronary heart disease, and hypertension: links to the aleurone preferred over indigestible fiber Common variants of the G protein-coupled receptor type 4 are associated with human essential hypertension and predict the blood pressure response to angiotensin receptor blockade.25 by 25: Achieving Global Reduction in Cardiovascular Mortality A linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: the virtual renal biopsy.Diagnostic tools for hypertension and salt sensitivity testing.Understanding the patterns and trends of sodium intake, potassium intake, and sodium to potassium ratio and their effect on hypertension in China Salt intake and cardiovascular disease: why are the data inconsistent?Identifying predictors of high sodium excretion in patients with heart failure: a mixed effect analysis of longitudinal data.Neurogenic and sympathoexcitatory actions of NaCl in hypertension.Lower potassium intake is associated with increased wave reflection in young healthy adults.Cardiovascular disease in CKD in 2012: moving forward, slowly but surely.Vascular effects of dietary salt.Dietary sodium and potassium intake is not associated with elevated blood pressure in US adults with no prior history of hypertension.Measurement error corrected sodium and potassium intake estimation using 24-hour urinary excretion.Estimation of 24-hour urinary sodium excretion using spot urine samples.Use of Urine Biomarkers to Assess Sodium Intake: Challenges and Opportunities Reported high salt intake is associated with increased prevalence of abdominal aortic aneurysm and larger aortic diameter in older men.Dietary salt intake and hypertension.Urinary sodium excretion and dietary sources of sodium intake in Chinese postmenopausal women with prehypertension Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease.Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study Lower levels of sodium intake and reduced cardiovascular risk.What determines human sodium intake: policy or physiology?Estimation of daily salt intake through a 24-hour urine collection in Pohang, Korea Effect of lower sodium intake on health: systematic review and meta-analyses.Dietary salt reduction and cardiovascular disease rates in India: a mathematical model.The science upon which to base dietary sodium policy.Using Decomposition Analysis to Identify Modifiable Racial Disparities in the Distribution of Blood Pressure in the United States.The feasibility of achieving low-sodium intake in diets that are also nutritious, low-cost, and have familiar meal components.Congestive heart failure adherence redesign trial: a pilot study.Dietary salt intake exaggerates sympathetic reflexes and increases blood pressure variability in normotensive rats Projected impact of a sodium consumption reduction initiative in Argentina: an analysis from the CVD policy model--Argentina.Normalisation of urinary biomarkers to creatinine for clinical practice and research--when and why.Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats.

P2860

Q22306540-1CBF89A1-6151-4D64-806A-95BEF6D0AD16 Q24187211-97C787DA-3ED3-479E-BC99-3EF209C8227D Q24197603-21AD5312-15A3-4D77-8837-C627EAE92F5C Q26752732-2F24F610-1FB1-43AD-B507-321FDA58EA68 Q26782788-90362F86-ED54-4484-9AC1-2408A37463D5 Q26796222-13EE7651-1DBC-4706-9CDE-6809A8DD7BBE Q26823966-7E7A6FA8-FEC2-4A83-858F-D05140A77C51 Q30300484-7602160E-355B-423D-9016-F83B26981C71 Q30379675-A76B0FBE-72E1-436C-B4E5-4A4E2088077A Q30412608-3839F260-90ED-450F-9B5A-2C8B94BB46BF Q30417367-077D19FA-503B-4E10-B92C-2EA8E71725CC Q30564823-0D2274F0-2DF9-4F66-82F4-DEBF6DD2CE3D Q30582625-F8358869-0EED-4001-87E4-5F5557717269 Q30724090-3A2A59E2-29E0-4DC7-8260-F5F09F82D613 Q33598143-F95F972B-A204-4D84-9039-94F53D105863 Q33676986-3B90180B-E6EA-45A3-885A-21ABDF9160FE Q33682243-45ECB3FF-4B5D-43B1-9090-40D761A0E2EC Q33683941-7974D6C1-329F-429D-8C70-86210B8634B2 Q33769796-AE490942-9A6C-4BD7-995F-F2C05839DC90 Q33805361-E0090287-AEBF-4002-823E-2376333016BC Q33813751-DC3E33F2-7486-4949-AD94-509761A52AF2 Q33872013-F232D086-AE53-4CAC-AC96-3340E60F0BCD Q33921350-A431768E-4091-417F-A506-634BF443AE49 Q33927609-FE6B9D3D-CDEA-487D-BED6-271CD4BDBE14 Q33989604-FAC74A47-21E8-4AF9-A050-9ACC69CA1A90 Q34111619-4F40E401-2F55-46E3-81D2-3BDFA10F26AA Q34273506-34FCAED9-F355-48E3-8DE9-1ABA12D3B46B Q34274962-1FB2EC00-8BDC-4E15-B15D-D2DBEBF0912A Q34300242-F6ADB84E-E7CC-4ED0-AA90-A6A0B2252D4F Q34325412-A53DC2C7-8C8C-4F49-B031-33FCD5473F25 Q34337227-06077667-4771-49CA-A5B9-70684D8C838D Q34412172-7C20124C-DD89-4E53-9106-4B8769B2366B Q34471911-C3AEA5B4-4FD4-48A2-A688-80BB82EA2E48 Q34486317-FCFEA69D-EA64-4753-BCD2-F340683C7780 Q34625919-03C2FF71-9336-4DA0-873D-5AAE5F89B3B3 Q34635174-D23E2DD9-735E-487F-8BE5-C1C243097AA1 Q34711079-5E470407-F6E6-4FBB-85AA-06B98F5C0B3F Q34989374-FBE614A9-D669-482B-933A-C9FC8FC9BA69 Q35076289-4FCC6C8C-BDF2-4833-9A8B-5015B74420E5 Q35106649-DB50CD11-2846-48D3-B9B5-D0F3ED54EBFF

P2860

Urinary sodium and potassium excretion and risk of cardiovascular events.

http://www.wikidata.org/entity/Q46714861

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Urinary sodium and potassium excretion and risk of cardiovascular events.

@en

Urinary sodium and potassium excretion and risk of cardiovascular events.

@nl

type

label

Urinary sodium and potassium excretion and risk of cardiovascular events.

@en

Urinary sodium and potassium excretion and risk of cardiovascular events.

@nl

prefLabel

Urinary sodium and potassium excretion and risk of cardiovascular events.

@en

Urinary sodium and potassium excretion and risk of cardiovascular events.

@nl

P1433

Q46714861-6676FCE9-5EC3-4DBB-8DEB-73AC51B2387C

P1476

Q46714861-5A1A7053-E53E-433D-86F6-C51513C1637E

P2093

Q46714861-0D59F275-31F0-499B-B826-1284D0FF4772

Q46714861-13C7205E-9134-4A91-8530-54A8DF747D17

Q46714861-21ED7A52-59B7-4F92-BDB4-3D2B759861BA

Q46714861-457DEA83-3246-4EAD-89A3-D31D4A913584

Q46714861-6796E7F3-56FD-45ED-A36C-3EA0D63DCEA6

Q46714861-78BB67FF-BF65-4999-842A-082C428FFB5F

Q46714861-9B4FF32E-0B51-4176-A0A2-F40978A509F0

Q46714861-9D717C4E-BFC7-47CD-8D2C-64453220076E

Q46714861-C87CE088-C7DA-431C-9B48-69A03735B496

P304

Q46714861-DA8AA51F-C501-41A1-A622-8498AF140686

P31

Q46714861-BE2B3514-95F4-494E-8302-45C69B4642C8

P356

Q46714861-12FBDEC0-B4C3-4F12-97B1-CED0E2A4B623

P407

Q46714861-DDE2488A-A526-4C18-B53F-D55BF369BCFD

P433

Q46714861-82C180BC-BCB5-4073-B008-67A708CA937B

P478

Q46714861-E7091F09-F348-440C-BBE7-688A922F5102

P50

Q46714861-004F3DF8-6611-4937-95F9-A440B6368B6E

Q46714861-77C5C8FA-C50B-4D17-B742-C80B5C26D51E

Q46714861-BFF4ED9A-F361-4CBD-BDE6-C7948905E32B

P577

Q46714861-E373889C-4518-49EC-862D-44B266198B78

P5875

Q46714861-64461850-1B40-4F69-9F2D-EF14DB8C5D95

P698

Q46714861-10758FB4-CCCD-422F-9D30-E06EB26868AC

P921

Q46714861-2A1B239A-1A55-4E09-BE5C-1E4D0E0DC5E4

P356

P1433

Journal of the American Medical Association

P1476

Urinary sodium and potassium excretion and risk of cardiovascular events.

@en

P2093

Andrew Mente

http://www.w3.org/2001/XMLSchema#string

Antonio Dans

http://www.w3.org/2001/XMLSchema#string

Arya M Sharma

http://www.w3.org/2001/XMLSchema#string

Jeffrey Probstfield

http://www.w3.org/2001/XMLSchema#string

Johannes F Mann

http://www.w3.org/2001/XMLSchema#string

Matthew McQueen

http://www.w3.org/2001/XMLSchema#string

Peggy Gao

http://www.w3.org/2001/XMLSchema#string

Peter Sleight

http://www.w3.org/2001/XMLSchema#string

Roland E Schmieder

http://www.w3.org/2001/XMLSchema#string

P304

2229-2238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2011.1729

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

306

http://www.w3.org/2001/XMLSchema#string

P50

Martin O'Donnell

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51823663

http://www.w3.org/2001/XMLSchema#string

P698

22110105

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio